A center focused on improving treatments for childhood cystic kidney disease.
UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC) - Clinical, Translational, and Biorepository Resource
This study is working to improve treatments for cystic kidney disease by collecting information and samples from patients across the Americas, so researchers can find better ways to slow down the disease and help kids with this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10884924 on NIH RePORTER |
What this research studies
The UAB Childhood Cystic Kidney Disease Core Center aims to enhance research and treatment options for cystic kidney disease by collaborating with other centers to streamline the process of developing new therapies. This center will gather clinical data and biological samples from patients across the Americas, allowing researchers to study the disease more effectively. By creating patient-relevant models and utilizing advanced imaging techniques, the center seeks to identify and test potential treatments that could slow disease progression. The multidisciplinary team will also work to recruit new scientists into this important field of research.
Who could benefit from this research
Good fit: Ideal candidates for this research include children diagnosed with cystic kidney diseases such as Autosomal Dominant Polycystic Kidney Disease (ADPKD) or Autosomal Recessive Polycystic Kidney Disease (ARPKD).
Not a fit: Patients with cystic kidney diseases who are not children or do not meet the specific criteria for the study may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for childhood cystic kidney disease, improving patient outcomes.
How similar studies have performed: Other research initiatives focusing on cystic kidney disease have shown promise in developing new therapeutic approaches, indicating that this collaborative model could be effective.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Guay-Woodford, Lisa Marie — University of Alabama at Birmingham
- Study coordinator: Guay-Woodford, Lisa Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.